Board Meeting

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2325.356.7 (+0.29 %)
PREV CLOSE ( ) 2318.65
OPEN PRICE ( ) 2313.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1907
TODAY'S LOW / HIGH ( )2288.60 2336.25
52 WK LOW / HIGH ( )1874.3 2766.85
NSE2327.407.35 (+0.32 %)
PREV CLOSE( ) 2320.05
OPEN PRICE ( ) 2300.00
BID PRICE (QTY) 2327.40 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 230548
TODAY'S LOW / HIGH( ) 2282.70 2339.05
52 WK LOW / HIGH ( )1872.55 2767.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.